anayamalik, Author at European Medical Journal - Page 73 of 83

How Does Asthma Alter Children’s Memory Development?

Children with asthma, particularly those with an early onset, may experience slower memory development and face challenges in cognitive functions.

New Algorithm Enhances Precision in Long COVID Cohorts

Researchers have developed a precision phenotyping algorithm that significantly advances the identification of long COVID, or post-acute sequelae of COVID-19 (PASC), in patient records.

Newborn Genome Screening Shows 99.6% Success Rate

In a landmark study conducted across six New York City hospitals, researchers have found that genomic sequencing can significantly enhance newborn screening by detecting additional actionable conditions beyond the current standard newborn screening (NBS) program.

New Genetic Insight on Leukemia Treatment Resistance

A genetic variant, the BIM deletion polymorphism (BDP), has been identified by researchers to significantly enhance leukemia stem and progenitor cells’ survival, making them resistant to common targeted therapies.

Once-Weekly Semaglutide: Relief for Knee Pain?

In a groundbreaking study, once-weekly semaglutide injections were shown to significantly reduce both knee osteoarthritis pain and body weight in adults with obesity, offering promising new relief for patients with limited treatment options.

Unequal Insurance Coverage Worsens Cancer Outcomes

A powerful link between health insurance status and racial and ethnic disparities in advanced cancer diagnoses has been identified in a recently published study.

Emerging Evidence for Laser Hair Removal in Treating Hidradenitis Suppurativa

New evidence highlights the potential of laser hair removal and intense pulsed light (IPL) therapy in reducing lesion count and flare-ups for patients with hidradenitis suppurativa (HS).

FDA Proposes OTC Ban for Oral Phenylephrine

The FDA has announced it is proposing removing oral phenylephrine from the list of over-the-counter (OTC) nasal decongestant ingredients due to extensive evidence questioning its effectiveness.

RSV Vaccines Validated: Cuts Hospitalizations, ICU Admissions

New research highlights the significant impact of Respiratory Syncytial Virus (RSV) vaccines in reducing severe respiratory illness among older adults, a group disproportionately affected by RSV.

Poor Sleep Doubles Cognitive Decline Risk

A recent study highlights how sleep disturbances, especially daytime dysfunction, excessive sleepiness and lower enthusiasm, may significantly increase the risk of motoric cognitive risk (MCR) syndrome in older adults.